Keyphrases
Active Matrix
16%
Complication Prevention
16%
Control Subjects
16%
Diabetes
33%
Diabetes Complications
16%
Exercise-induced
100%
Healthy Controls
16%
Matrix metalloproteinase-2 (MMP-2)
16%
Matrix Metalloproteinases
100%
Messenger RNA (mRNA)
50%
Physical Training
16%
Protein Response
16%
Response to Training
16%
Skeletal muscle
100%
Tissue Inhibitors
16%
Type 2 Diabetes Mellitus (T2DM)
100%
Uncontrolled Type 2 Diabetes
16%
Vascular Remodeling
16%
Medicine and Dentistry
Diabetes
50%
Diseases
16%
Gelatinase A
16%
Matrix Metalloproteinase
100%
Maturity Onset Diabetes of the Young
100%
Messenger RNA
50%
Metalloprotease Inhibitor
33%
Skeletal Muscle
100%
Type 2 Diabetes
66%
Vascular Remodeling
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
16%
Gelatinase A
16%
Matrix Metalloproteinase
100%
Messenger RNA
50%
Non Insulin Dependent Diabetes Mellitus
100%
Tissue Inhibitor of Metalloproteinase
33%
Vascular Remodeling
16%
Nursing and Health Professions
Diseases
16%
Gelatinase A
16%
Matrix Metalloproteinase
100%
Messenger RNA
50%
Non Insulin Dependent Diabetes Mellitus
100%
Tissue Inhibitor of Metalloproteinase
33%
Vascular Remodeling
16%
Neuroscience
Matrix Metalloproteinase
100%
Messenger RNA
50%
Metalloprotease Inhibitor
33%
MMP2
16%
Skeletal Muscle
100%
Immunology and Microbiology